Assessment flow chart
Screening | Follow-up | |||||||
Baseline | Randomisation | Immediately postoperative | 24±6 hours | 48±12 hours | 72±12 hours | 7 days±12 hour or at discharge | 90±7 days | |
Inclusion/exclusion criteria | x | |||||||
Informed consent | x | |||||||
Randomisation | x | |||||||
Demographics | x | |||||||
Medical history | x | |||||||
Previous medication | x | |||||||
Vital signs | x | x | x | x | X | x | ||
Physical examination | x | |||||||
Laboratory tests | x | x | x | X | x | |||
Prestroke mRS | x | |||||||
mRS | x | |||||||
NIHSS score | x | x | X | x | ||||
Brain CT plus CTP/MRI | x | |||||||
CTA/MRA/DSA | x | X | ||||||
Brain CT/MRI | X | |||||||
ASPECTS | x | |||||||
mTICI score | x | |||||||
AOL grade | X | |||||||
Comedication | x | x | x | X | x | x | ||
Barthel index | x | |||||||
EQ-5D | x | |||||||
AE/SAE | x | x | x | X | x | x |
AE, adverse event; ASPECTS, Alberta Stroke Programme Early CT Score; CTA, CT angiography; CTP, CT perfusion; DSA, digital subtraction angiography; EQ-5D, EuroQol 5 Dimensions Questionnaire; AOL grade, American Society of Interventional and Therapeutic Neuroradiology (ASITN)-Society of Interventional Radiology (SIR) Grading System for Thrombolysis in Acute Ischaemic Stroke; MRA, MR angiography; mRS, modified Rankin scale; mTICI, modified Thrombolysis in Cerebral Infarction; NIHSS, National Institute of Health Stroke Scale; SAE, serious adverse event; TOAST, Trial of Org 10 172 in Acute Stroke Treatment classification.